We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+23.78%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$185M
AUM Growth
+$16.5M
(+9.8%)
Cap. Flow
-$100M
Cap. Flow
% of AUM
-54.06%
Top 10 Holdings %
Top 10 Hldgs %
35.61%
Holding
185
New
26
Increased
36
Reduced
26
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ELVA
Electrovaya
ELVA
|
+$2.28M |
| 2 |
PROF
Profound Medical
PROF
|
+$1.53M |
| 3 |
SCPH
scPharmaceuticals
SCPH
|
+$1.33M |
| 4 |
LivePerson
LPSN
|
+$1.23M |
| 5 |
Red Cat Holdings
RCAT
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aviat Networks
AVNW
|
+$2.34M |
| 2 |
Everspin Technologies
MRAM
|
+$2.08M |
| 3 |
Markel Group
MKL
|
+$1.23M |
| 4 |
Broadwind
BWEN
|
+$793K |
| 5 |
argenx
ARGX
|
+$737K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.35% |
| 2 | Technology | 13.11% |
| 3 | Financials | 6.55% |
| 4 | Industrials | 6.29% |
| 5 | Real Estate | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Mama's Creations
MAMA
$886M
| $62.6K | 0.03% |
12,756
+1,006
| +9% | +$3.97K |
|
|
MDRX
77
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
| $62.6K | 0.03% |
+120,400
| New | +$1.48M |
|
78
PUT
Sarepta Therapeutics
SRPT
$1.64B
| $55.3K | 0.03% |
+49,800
| New | +$4.78M |
|
|
INFN
79
DELISTED
Infinera Corporation Common Stock
INFN
| $53.4K | 0.03% |
+11,250
| New | +$44.3K |
|
80
Evolv Technologies
EVLV
$1.02B
| $53K | 0.03% |
+11,229
| New | +$48K |
|
|
KORE
81
DELISTED
KORE Group Holdings
KORE
| $36.3K | 0.02% |
+7,408
| New | +$21.3K |
|
82
Neuronetics
STIM
$152M
| $30.2K | 0.02% |
+10,405
| New | +$16.4K |
|
|
DFSCW
83
DEFSEC Technologies Warrant
DFSCW
| $25.8K | 0.01% |
282,092
+134,739
| +91% | +$20.1K |
|
|
SVREW
84
SaverOne 2014 Ltd Warrant
SVREW
$48.9K
| $16.9K | 0.01% |
140,864
-500
| -0.4% | -$89 |
|
85
Aclarion Warrant
ACONW
| $15.3K | 0.01% |
286,276
+107,860
| +60% | +$3.69K |
|
|
GES
86
PUT
DELISTED
Guess Inc
GES
| $10.5K | 0.01% |
18,200
| – | – |
|
87
PUT
Tandem Diabetes Care
TNDM
$1.39B
| $9.36K | 0.01% |
+62,400
| New | +$1.29M |
|
88
PUT
Cinemark Holdings
CNK
$4.38B
| $8.85K | ﹤0.01% |
118,000
+200
| +0.2% | +$3.11K |
|
89
PUT
Wayfair
W
$11.8B
| $8.07K | ﹤0.01% |
46,700
+9,100
| +24% | +$476K |
|
90
CALL
SIGA Technologies
SIGA
$230M
| $7.55K | ﹤0.01% |
+75,500
| New | +$404K |
|
91
PUT
A10 Networks
ATEN
$2.15B
| $6.75K | ﹤0.01% |
+38,600
| New | +$468K |
|
|
VRNA
92
PUT
DELISTED
Verona Pharma
VRNA
| $5.7K | ﹤0.01% |
+15,200
| New | +$224K |
|
93
CALL
Amylyx Pharmaceuticals
AMLX
$2.21B
| $5.02K | ﹤0.01% |
22,300
| – | – |
|
94
PUT
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
| $4.71K | ﹤0.01% |
37,700
+27,600
| +273% | +$601K |
|
95
PUT
Bread Financial
BFH
$4.5B
| $3.34K | ﹤0.01% |
+10,600
| New | +$317K |
|
96
PUT
The GEO Group
GEO
$4.2B
| $2.96K | ﹤0.01% |
115,400
| – | – |
|
97
PUT
Southwest Airlines
LUV
$22.8B
| $1.81K | ﹤0.01% |
41,000
| – | – |
|
98
PUT
Barclays
BCS
$93.5B
| $837 | ﹤0.01% |
52,800
+400
| +0.8% | +$2.88K |
|
99
PUT
Carnival Corporation Ltd
CCL
$39.2B
| $821 | ﹤0.01% |
82,100
-37,300
| -31% | -$541K |
|
100
PUT
iShares S&P 100 ETF
OEF
$20.1B
| $570 | ﹤0.01% |
11,400
-199,900
| -95% | -$42M |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Worth Venture Partners held 185 positions worth $185M, up 9.8% from $169M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Worth Venture Partners withdrew a net $100M in Q4 2023, closing 56 positions and reducing 26 holdings. Its most notable exit was Aviat Networks, an estimated $2.34M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
Against the trend, Worth Venture Partners opened a new position in Electrovaya worth $2.51M.
- Worth Venture Partners's largest Q4 2023 buy was Electrovaya: 820,538 shares worth $2.51M.
- Worth Venture Partners added most to scPharmaceuticals in Q4 2023, an estimated $1.33M increase.
- Worth Venture Partners's biggest Q4 2023 reduction was Apollo Global Management, cutting an estimated $662K.
- Worth Venture Partners fully exited Aviat Networks in Q4 2023, selling an estimated $2.34M.
- Worth Venture Partners's ten largest holdings make up 36% of its $185M portfolio in Q4 2023.
- Worth Venture Partners opened 26 new positions and closed 56 in Q4 2023.
- Worth Venture Partners's portfolio value rose 9.8% quarter-over-quarter to $185M.
Based on Worth Venture Partners's 13F filing for Q4 2023, filed 9 Feb 2024.